标题/作者	年份
Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer VA Avanzato, MJ Matson, SN Seifert, R Pryce, BN Williamson, SL Anzick, ... Cell 183 (7), 1901-1912. e9	2020
Convalescent plasma antibody levels and the risk of death from Covid-19 MJ Joyner, RE Carter, JW Senefeld, SA Klassen, JR Mills, PW Johnson, ... New England Journal of Medicine 384 (11), 1015-1027	2021
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study STH Liu, HM Lin, I Baine, A Wajnberg, JP Gumprecht, F Rahman, ... Nature medicine 26 (11), 1708-1713	2020
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review KL Chai, SJ Valk, V Piechotta, C Kimber, I Monsef, C Doree, EM Wood, ... Cochrane Database of Systematic Reviews	2020
Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience MJ Joyner, JW Senefeld, SA Klassen, JR Mills, PW Johnson, ES Theel, ... medrxiv, 2020.08. 12.20169359	2020
Emerging treatment strategies for COVID-19 infection M Gavriatopoulou, I Ntanasis-Stathopoulos, E Korompoki, D Fotiou, ... Clinical and experimental medicine 21, 167-179	2021
Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality E Salazar, PA Christensen, EA Graviss, DT Nguyen, B Castillo, J Chen, ... The American journal of pathology 190 (11), 2290-2303	2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 X Chen, Z Pan, S Yue, F Yu, J Zhang, Y Yang, R Li, B Liu, X Yang, L Gao, ... Signal transduction and targeted therapy 5 (1), 180	2020
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein C Kim, DK Ryu, J Lee, YI Kim, JM Seo, YG Kim, JH Jeong, M Kim, JI Kim, ... Nature communications 12 (1), 288	2021
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy Q Zhang, R Xiang, S Huo, Y Zhou, S Jiang, Q Wang, F Yu Signal transduction and targeted therapy 6 (1), 233	2021
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes WN Voss, YJ Hou, NV Johnson, G Delidakis, JE Kim, K Javanmardi, ... Science 372 (6546), 1108-1112	2021
The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis SA Klassen, JW Senefeld, PW Johnson, RE Carter, CC Wiggins, ... Mayo Clinic Proceedings 96 (5), 1262-1275	2021
Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization E Salazar, SV Kuchipudi, PA Christensen, T Eagar, X Yi, P Zhao, Z Jin, ... The Journal of clinical investigation 130 (12), 6728-6738	2020
Convalescent plasma therapy for COVID-19: state of the art D Focosi, AO Anderson, JW Tang, M Tuccori Clinical microbiology reviews 33 (4), 10.1128/cmr. 00072-20	2020
Significantly decreased mortality in a large cohort of coronavirus disease 2019 (COVID-19) patients transfused early with convalescent plasma containing high-titer anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein IgG E Salazar, PA Christensen, EA Graviss, DT Nguyen, B Castillo, J Chen, ... The American journal of pathology 191 (1), 90-107	2021
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2 C Riggioni, P Comberiati, M Giovannini, I Agache, M Akdis, ... Allergy 75 (10), 2503-2541	2020
Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies M Lopes-Pacheco, PL Silva, FF Cruz, D Battaglini, C Robba, P Pelosi, ... Frontiers in physiology 12, 593223	2021
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease P Wang, L Liu, MS Nair, MT Yin, Y Luo, Q Wang, T Yuan, K Mori, AG Solis, ... Emerging microbes & infections 9 (1), 2091-2093	2020
SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors SE Benner, EU Patel, O Laeyendecker, A Pekosz, K Littlefield, Y Eby, ... The Journal of infectious diseases 222 (12), 1974-1984	2020
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity MG Joyce, WH Chen, RS Sankhala, A Hajduczki, PV Thomas, M Choe, ... Cell reports 37 (12)	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。